NO20082075L - Anti-hyperkolesterolemiske forbindelser - Google Patents
Anti-hyperkolesterolemiske forbindelserInfo
- Publication number
- NO20082075L NO20082075L NO20082075A NO20082075A NO20082075L NO 20082075 L NO20082075 L NO 20082075L NO 20082075 A NO20082075 A NO 20082075A NO 20082075 A NO20082075 A NO 20082075A NO 20082075 L NO20082075 L NO 20082075L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- cholesterol
- hypercholesterolemic compounds
- hypercholesterolemic
- esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72378105P | 2005-10-05 | 2005-10-05 | |
PCT/US2006/038551 WO2007044318A2 (fr) | 2005-10-05 | 2006-09-29 | Composés anti-hypercholestérolémiques |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082075L true NO20082075L (no) | 2008-07-04 |
Family
ID=37845278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082075A NO20082075L (no) | 2005-10-05 | 2008-05-02 | Anti-hyperkolesterolemiske forbindelser |
Country Status (25)
Country | Link |
---|---|
US (2) | US20090137546A1 (fr) |
EP (1) | EP1934175B1 (fr) |
JP (1) | JP4879991B2 (fr) |
KR (1) | KR20080050610A (fr) |
CN (1) | CN101277930A (fr) |
AR (1) | AR058068A1 (fr) |
AT (1) | ATE488495T1 (fr) |
AU (1) | AU2006302584B2 (fr) |
BR (1) | BRPI0616834A2 (fr) |
CA (1) | CA2624481C (fr) |
CR (1) | CR9903A (fr) |
DE (1) | DE602006018341D1 (fr) |
DO (1) | DOP2006000211A (fr) |
EA (1) | EA200801008A1 (fr) |
ES (1) | ES2354460T3 (fr) |
GT (1) | GT200600444A (fr) |
IL (1) | IL190434A0 (fr) |
MA (1) | MA30006B1 (fr) |
NO (1) | NO20082075L (fr) |
PE (1) | PE20070493A1 (fr) |
SV (1) | SV2009002863A (fr) |
TN (1) | TNSN08153A1 (fr) |
TW (1) | TW200806623A (fr) |
WO (1) | WO2007044318A2 (fr) |
ZA (1) | ZA200802587B (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7176193B2 (en) * | 2002-06-19 | 2007-02-13 | Sanofi-Aventis Deutschland Gmbh | Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
GB0215579D0 (en) * | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
GB0329778D0 (en) * | 2003-12-23 | 2004-01-28 | Astrazeneca Ab | Chemical compounds |
EP1699760B1 (fr) * | 2003-12-23 | 2017-05-17 | Merck Sharp & Dohme Corp. | Composes anti-hypercholesterolemie |
SA04250427A (ar) * | 2003-12-23 | 2005-12-03 | استرازينيكا ايه بي | مشتقات ثاني فينيل أزيتيدون |
UY29607A1 (es) * | 2005-06-20 | 2007-01-31 | Astrazeneca Ab | Compuestos quimicos |
AR057383A1 (es) * | 2005-06-22 | 2007-12-05 | Astrazeneca Ab | Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto |
SA06270191B1 (ar) * | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
AR054482A1 (es) * | 2005-06-22 | 2007-06-27 | Astrazeneca Ab | Derivados de azetidinona para el tratamiento de hiperlipidemias |
MY148538A (en) * | 2005-06-22 | 2013-04-30 | Astrazeneca Ab | Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
AR057380A1 (es) * | 2005-06-22 | 2007-11-28 | Astrazeneca Ab | Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos |
TW200806623A (en) * | 2005-10-05 | 2008-02-01 | Merck & Co Inc | Anti-hypercholesterolemic compounds |
DE102005055726A1 (de) * | 2005-11-23 | 2007-08-30 | Sanofi-Aventis Deutschland Gmbh | Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
TW200811098A (en) * | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
JP2010513485A (ja) * | 2006-12-20 | 2010-04-30 | メルク・シャープ・エンド・ドーム・コーポレイション | 抗高コレステロール血症化合物 |
DE102009023046B4 (de) | 2008-05-30 | 2016-10-13 | Hyundai Motor Company | Automatisch schaltbares Getriebe eines Kraftfahrzeuges |
WO2010056788A1 (fr) * | 2008-11-17 | 2010-05-20 | Merck Sharp & Dohme Corp. | Composés anti-hypercholestérolémiques |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL102582A0 (en) * | 1991-07-23 | 1993-01-14 | Schering Corp | Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
MX9606319A (es) * | 1994-06-20 | 1997-05-31 | Schering Corp | Compuestos de acetidinonas sustituidas utiles como agentes hipocolesterolemicos. |
US5624920A (en) * | 1994-11-18 | 1997-04-29 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
ATE349425T1 (de) * | 2000-12-21 | 2007-01-15 | Sanofi Aventis Deutschland | Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen |
TWI291957B (en) * | 2001-02-23 | 2008-01-01 | Kotobuki Pharmaceutical Co Ltd | Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same |
US7176194B2 (en) * | 2002-06-19 | 2007-02-13 | Sanofi-Aventis Deutschland Gmbh | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
US7176193B2 (en) * | 2002-06-19 | 2007-02-13 | Sanofi-Aventis Deutschland Gmbh | Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
MXPA05009503A (es) * | 2003-03-07 | 2005-10-18 | Schering Corp | Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
JP2005015434A (ja) * | 2003-06-27 | 2005-01-20 | Kotobuki Seiyaku Kk | 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤 |
EP1699760B1 (fr) * | 2003-12-23 | 2017-05-17 | Merck Sharp & Dohme Corp. | Composes anti-hypercholesterolemie |
EP1851197A2 (fr) * | 2005-02-09 | 2007-11-07 | Microbia, Inc. | Derives de phenylazetidinone |
WO2006138163A2 (fr) * | 2005-06-15 | 2006-12-28 | Merck & Co., Inc. | Composes anti-hypercholesterolemiques |
TW200806623A (en) * | 2005-10-05 | 2008-02-01 | Merck & Co Inc | Anti-hypercholesterolemic compounds |
DE102005055726A1 (de) * | 2005-11-23 | 2007-08-30 | Sanofi-Aventis Deutschland Gmbh | Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
CA2668094A1 (fr) * | 2006-11-02 | 2008-05-08 | Sanofi-Aventis Deutschland Gmbh | Nouvelle diphenylazetidinone substituee par l'acide piperazin-1-sulfonique presentant des proprietes pharmacologiques ameliorees |
-
2006
- 2006-09-26 TW TW095135631A patent/TW200806623A/zh unknown
- 2006-09-27 AR ARP060104231A patent/AR058068A1/es unknown
- 2006-09-29 CA CA2624481A patent/CA2624481C/fr not_active Expired - Fee Related
- 2006-09-29 ES ES06816084T patent/ES2354460T3/es active Active
- 2006-09-29 DE DE602006018341T patent/DE602006018341D1/de active Active
- 2006-09-29 AU AU2006302584A patent/AU2006302584B2/en not_active Ceased
- 2006-09-29 CN CNA2006800369359A patent/CN101277930A/zh active Pending
- 2006-09-29 KR KR1020087008305A patent/KR20080050610A/ko not_active Application Discontinuation
- 2006-09-29 EP EP06816084A patent/EP1934175B1/fr active Active
- 2006-09-29 WO PCT/US2006/038551 patent/WO2007044318A2/fr active Application Filing
- 2006-09-29 BR BRPI0616834A patent/BRPI0616834A2/pt not_active IP Right Cessation
- 2006-09-29 EA EA200801008A patent/EA200801008A1/ru unknown
- 2006-09-29 US US11/992,990 patent/US20090137546A1/en not_active Abandoned
- 2006-09-29 JP JP2008534613A patent/JP4879991B2/ja not_active Expired - Fee Related
- 2006-09-29 AT AT06816084T patent/ATE488495T1/de not_active IP Right Cessation
- 2006-10-03 PE PE2006001201A patent/PE20070493A1/es not_active Application Discontinuation
- 2006-10-03 GT GT200600444A patent/GT200600444A/es unknown
- 2006-10-04 US US11/542,966 patent/US7704988B2/en not_active Expired - Fee Related
- 2006-10-05 DO DO2006000211A patent/DOP2006000211A/es unknown
-
2008
- 2008-03-20 ZA ZA200802587A patent/ZA200802587B/xx unknown
- 2008-03-25 IL IL190434A patent/IL190434A0/en unknown
- 2008-04-04 SV SV2008002863A patent/SV2009002863A/es not_active Application Discontinuation
- 2008-04-04 TN TNP2008000153A patent/TNSN08153A1/en unknown
- 2008-04-18 CR CR9903A patent/CR9903A/es not_active Application Discontinuation
- 2008-05-02 MA MA30894A patent/MA30006B1/fr unknown
- 2008-05-02 NO NO20082075A patent/NO20082075L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101277930A (zh) | 2008-10-01 |
GT200600444A (es) | 2007-05-04 |
CA2624481C (fr) | 2012-04-03 |
ZA200802587B (en) | 2009-06-24 |
US20090137546A1 (en) | 2009-05-28 |
CR9903A (es) | 2008-07-29 |
AU2006302584B2 (en) | 2011-10-13 |
DE602006018341D1 (de) | 2010-12-30 |
JP2009511475A (ja) | 2009-03-19 |
DOP2006000211A (es) | 2007-05-31 |
PE20070493A1 (es) | 2007-06-13 |
US7704988B2 (en) | 2010-04-27 |
ES2354460T3 (es) | 2011-03-15 |
BRPI0616834A2 (pt) | 2016-08-23 |
MA30006B1 (fr) | 2008-12-01 |
EA200801008A1 (ru) | 2009-02-27 |
JP4879991B2 (ja) | 2012-02-22 |
ATE488495T1 (de) | 2010-12-15 |
WO2007044318A3 (fr) | 2007-07-12 |
IL190434A0 (en) | 2008-11-03 |
SV2009002863A (es) | 2009-02-19 |
KR20080050610A (ko) | 2008-06-09 |
EP1934175A2 (fr) | 2008-06-25 |
TNSN08153A1 (en) | 2009-10-30 |
TW200806623A (en) | 2008-02-01 |
AR058068A1 (es) | 2008-01-23 |
WO2007044318A2 (fr) | 2007-04-19 |
US20070078098A1 (en) | 2007-04-05 |
CA2624481A1 (fr) | 2007-04-19 |
EP1934175B1 (fr) | 2010-11-17 |
AU2006302584A1 (en) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082075L (no) | Anti-hyperkolesterolemiske forbindelser | |
WO2006138163A3 (fr) | Composes anti-hypercholesterolemiques | |
WO2005062824A3 (fr) | Composes anti-hypercholesterolemie | |
WO2007008529A3 (fr) | Agents modificateurs de l'absorption du cholesterol cellulaire | |
WO2006110816A3 (fr) | 1h-benzimidazole-4-carboxamides substitues avec un carbone quaternaire en position 2 tenant lieu d'inhibiteurs puissants de parp | |
WO2007059230A3 (fr) | 1h-benzimidazole-4-carboxamides substitues efficaces en tant qu’inhibiteurs de parp | |
WO2006121861A3 (fr) | Inhibiteurs d'absorption de biphenylazetidinone cholesterol | |
WO2007008541A3 (fr) | Modificateurs d'absorption de cholesterol cellulaire | |
IL187740A0 (en) | Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions | |
NO20092711L (no) | Metoder for anvendelse av cyclopaminanaloger | |
EP1896458A4 (fr) | Nouveaux dérivés de la 2-azétidinone en tant qu inhibiteurs de l'absorption du cholestérol pour le traitement de conditions d hyperlipidémie | |
NO20082088L (no) | Azetidiner som MEK-inhibitorer for behandling av proliferative sykdommer | |
NO20090202L (no) | Prolylhydroksylaseinhibitorer | |
UA96126C2 (ru) | Соединение для ингибирования активности rho киназы, фармацевтическая композиция, которая содержит такое соединение, и способ ингибирования активности rho киназы | |
NO20083923L (no) | Pyrazolkinoloner er potente parp-inhibitorer | |
DE602006010243D1 (de) | 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen | |
WO2008137084A3 (fr) | Diazaquinolones inhibant l'activité de la prolyl hydroxylase | |
WO2009073497A3 (fr) | Inhibiteurs des prolyl hydroxylases | |
NO20060632L (no) | Nye forbindelser og sammensettinger som omfatter steroler og/eller stanoler og kolesterolbiosynteseinhibitorer og anvendelse av disse i behandling eller forebygging av en rekke sykdommer og tilstander | |
WO2008073452A8 (fr) | Compositions, synthèse et procédés d'utilisation d'inhibiteurs de cholinestérase à base d'indanone | |
WO2007079199A3 (fr) | Inhibiteurs de métalloprotéases à base de bisamides substitués | |
WO2008130600A3 (fr) | Quinolones et azaquinolones inhibant la prolyl hydroxylase | |
EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
WO2006124713A3 (fr) | 4-biarylyl-1-phenylazetidin-2-ones | |
NO20064344L (no) | Caspaseinhibitorer og anvendelser derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |